Tag
Evaxion A/S
2 articles
Evaxion Shows Preclinical Success for CMV Vaccine
Evaxion A/S presented preclinical data on its AI‑discovered multi‑component CMV vaccine candidate EVX‑V1 at the International Herpesvirus Workshop 2026 in Montreal.
AI‑identified T‑cell epitopes impro
Evaxion Shows AI‑Designed CMV Vaccine Success
Evaxion A/S presented preclinical data on its AI‑designed CMV vaccine EVX‑V1 at the International Herpesvirus Workshop 2026 in Montreal.
The study showed AI‑discovered T‑cell epitopes improved control